Research Portal

College of Health & Behavioural Sciences (Pre-Aug 2018)

151 - 200 out of 1,758Page size: 50
Sort by: Title
  1. Published

    Alcohol, drugs, sex and violence: health risks and consequences in young British holidaymakers to the Balearics

    Hughes, K., Bellis, M. A., Whelan, G., Calafat, A., Juan, M. & Blay, N., 2009, In: Adicciones. 21, 4, p. 265-77 13 p.

    Research output: Contribution to journal › Article › peer-review

  2. Published

    Alcohol, nightlife and violence: the relative contributions of drinking before and during nights out to negative health and criminal justice outcomes

    Hughes, K., Anderson, Z., Morleo, M. & Bellis, M. A., Jan 2008, In: Addiction. 103, 1, p. 60-5 6 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Aligning Cultural Safety and Language Appropriate Practice: new horizons for nurse education.

    Roberts, G. W., Roberts, G. & Irvine, F., 1 Jan 2010.

    Research output: Contribution to conference › Paper

  4. Published

    Aligning cultural safety and language appropriate practice: new horizons for nurse education in a global community.

    Roberts, G. W., Roberts, G. & Irvine, F., 1 Jan 2010.

    Research output: Contribution to conference › Paper

  5. Published
  6. Published
  7. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

  8. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

  9. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  10. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  11. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  12. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  13. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  14. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Emtricitabine/tenofovir DF (Truvada)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  15. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Epoetin delta (Dynepo)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  16. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for STEMI.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  17. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for UA/NSTEMI.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  18. Published
  19. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  20. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Maraviroc (Celsentri) for treatment-experienced adults infected only with CCR5-tropic HIV-1.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

  21. Published
  22. Published
  23. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Rufinamide (Inovelon) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  24. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Stiripentol (Diacomit) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  25. Published
  26. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Tenofovir disoproxil fumarate (Viread) for the treatment of hepatitis B.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  27. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Teriparatide (Forsteo) for the treatment of osteoporosis in men at increased risk of fracture.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  28. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  29. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Trabectedin (Yondelis) for advanced soft tissue sarcoma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  30. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

  31. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Clofarabine (Evoltra)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  32. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Co-careldopa intestinal gel (Duodopa).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  33. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Darunavir (Prezista)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  34. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Chronic, accelerated or blast phase CML.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  35. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  36. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Dexrazoxane (Savene)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  37. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Emtricitabine (Emtriva)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  38. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Idursulfase (Elaprase)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  39. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Parathyroid hormone (Preotact)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  40. Published

    All Wales Medicines Strategy Group Final Appraisal Report – Tipranavir (Aptivus).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  41. Published

    All Wales Medicines Strategy Group Final Assessment Report – Agalsidase alfa (Replagal)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

  42. Published
  43. Published

    Alpha Values as a Function of Sample Size, Effect Size, and Power: Accuracy over Inference

    Bradley, M. T. & Brand, A., Jun 2013, In: Psychological Reports. 112, 3, p. 835-844

    Research output: Contribution to journal › Article › peer-review

  44. Published

    Alpha adrenoceptor agonist-induced microcirculatory oscillations are reduced in diabetic neuropathy.

    Schmiedel, O., Nurmikko, T. J., Schroeter, M. L., Whitaker, R. & Harvey, J. N., 1 Aug 2008, In: Microvascular Research. 76, 2, p. 124-131

    Research output: Contribution to journal › Article › peer-review

  45. Published

    An Art Gallery Access Programme for people with dementia: ‘You do it for the moment’

    Bird, M. J., MacPherson, S., Bird, M., Anderson, K., Davis, T. & Blair, A., 1 Sept 2009, In: Aging and Mental Health. 13, 5, p. 744-752

    Research output: Contribution to journal › Article › peer-review

  46. Published

    An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients

    Neal, R. D., Baird, R., Banks, I., Cameron, D., Chester, J., Earl, H., Flannagan, M., Januszewski, A., Kennedy, R., Payne, S., Samuel, E., Taylor, H., Agarwal, R., Ahmed, S., Archer, C., Board, R., Carser, J., Copson, E., Cunningham, D., Coleman, R., Glaser, A., Griffiths, R., Hall, G., Hall, M., Harari, D., Hawkins, M., Hill, M., Johnson, P., Jones, A., Kalsi, T., Karapanagiotou, E., Kemp, Z., Mansi, J., Marshall, E., Mitchell, A., Moe, M., Michie, C., Neal, R., Newsom-Davis, T., Norton, A., Osborne, R., Patel, G., Radford, J., Ring, A., Shaw, E., Skinner, R., Stark, D., Turnbull, S., Velikova, G., White, J., Young, A., Joffe, J. & Selby, P., 5 Jan 2016, In: Ecancermedical Science. 10, 608

    Research output: Contribution to journal › Article › peer-review

  47. Published

    An EU Code of Ethics for Socio-Economic Research

    Huws, U., Dench, S. & Iphofen, R., 1 Jan 2004, Institute for Employment Studies.

    Research output: Book/Report › Book

  48. Published

    An Economic Evaluation Supported by Qualitative Data About the Patient Concerns Inventory (PCI) versus Standard Treatment Pathway in the Management of Patients with Head and Neck Cancer

    Ezeofor, V., Spencer, L., Rogers, S. N., Kanatas, A., Lowe, D., Semple, C. J., Hanna, J. R., Yeo, S. T. & Edwards, R. T., May 2022, In: PharmacoEconomics - Open. 6, 3, p. 389-403 15 p.

    Research output: Contribution to journal › Article › peer-review

  49. Published

    An Integrated Care Pathway for the Problem Drinker in the Community.

    Sims, J. & Iphofen, R., 1 Mar 2003, In: Drug and Alcohol Professional. 3, 1, p. 24-30

    Research output: Contribution to journal › Article › peer-review

  50. Published

    An Occupational Therapy intervention for residents with stroke-related disabilities in UK Care Homes (OTCH): cluster randomised controlled trial with economic evaluation

    Sackley, C., Walker, M., Burton, C., Watkins, C., Mant, J., Roalfe, A., Wheatley, K., Sheehan, B., Sharp, L., Stant, K. E., Fletcher-Smith, J., Steel, K., Barton, G., Irving, L. & Peryer, G., Feb 2016, In: Health Technology Assessment. 20, 15

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 8 ...36 Next